引用本文: | 张必翔, 邹威. 仑伐替尼联合TACE辅助治疗术后高复发风险肝细胞癌患者: LANCE研究结果更新[J]. 循证医学, 2021, 21(6): 329-331. DOI: 10.12019/j.issn.1671-5144.2021.06.003 |
Citation: | ZHANG Bi-xiang, ZOU Wei. Adjuvant Lenvatinib in Combination With TACE for HCC Patients With High Risk of Postoperative Relapse: Updated of LANCE Study[J]. Journal of Evidence-Based Medicine, 2021, 21(6): 329-331. DOI: 10.12019/j.issn.1671-5144.2021.06.003 |